These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36650694)
21. [Treatment of diabetes in metabolic syndrome]. Pelikánova T Vnitr Lek; 2009; 55(7-8):637-45. PubMed ID: 19731868 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective. Thompson PL; Davis TME Clin Ther; 2017 May; 39(5):1012-1025. PubMed ID: 27863704 [TBL] [Abstract][Full Text] [Related]
23. Careful use to minimize adverse events of oral antidiabetic medications in the elderly. Scheen AJ Expert Opin Pharmacother; 2021 Nov; 22(16):2149-2165. PubMed ID: 33823723 [TBL] [Abstract][Full Text] [Related]
24. Drug interactions of clinical importance with antihyperglycaemic agents: an update. Scheen AJ Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007 [TBL] [Abstract][Full Text] [Related]
25. Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis. Wu Y; Liu HB; Shi XF; Song Y PLoS One; 2014; 9(6):e99577. PubMed ID: 24924771 [TBL] [Abstract][Full Text] [Related]
26. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Alvarez Guisasola F; Tofé Povedano S; Krishnarajah G; Lyu R; Mavros P; Yin D Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():25-32. PubMed ID: 18435671 [TBL] [Abstract][Full Text] [Related]
27. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. Karagiannis T; Paschos P; Paletas K; Matthews DR; Tsapas A BMJ; 2012 Mar; 344():e1369. PubMed ID: 22411919 [TBL] [Abstract][Full Text] [Related]
28. Update on cognitive decline and dementia in elderly patients with diabetes. Bordier L; Doucet J; Boudet J; Bauduceau B Diabetes Metab; 2014 Nov; 40(5):331-7. PubMed ID: 24703603 [TBL] [Abstract][Full Text] [Related]
29. [Oral hypoglycaemic agents in 2009]. Schwab S; Diem P Ther Umsch; 2009 Oct; 66(10):677-84. PubMed ID: 19830675 [TBL] [Abstract][Full Text] [Related]
30. Hypoglycemia, frailty and dementia in older people with diabetes: Reciprocal relations and clinical implications. Abdelhafiz AH; McNicholas E; Sinclair AJ J Diabetes Complications; 2016; 30(8):1548-1554. PubMed ID: 27524280 [TBL] [Abstract][Full Text] [Related]
31. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis. Liu SC; Tu YK; Chien MN; Chien KL Diabetes Obes Metab; 2012 Sep; 14(9):810-20. PubMed ID: 22486990 [TBL] [Abstract][Full Text] [Related]
32. Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies. Crabtree T; Ogendo JJ; Vinogradova Y; Gordon J; Idris I Expert Rev Endocrinol Metab; 2022 May; 17(3):255-267. PubMed ID: 35614863 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study. Gonzalez C; Monti C; Pinzon A; Monsanto H; Ejzykowicz F; Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):592-602. PubMed ID: 30076124 [TBL] [Abstract][Full Text] [Related]
34. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670 [TBL] [Abstract][Full Text] [Related]
35. Hypoglycaemic episodes in patients with type 2 diabetes--risk factors and associations with patient-reported outcomes: The PANORAMA Study. Simon D; de Pablos-Velasco P; Parhofer KG; Gönder-Frederick L; Duprat Lomon I; Vandenberghe H; Eschwège E; Bradley C Diabetes Metab; 2015 Dec; 41(6):470-9. PubMed ID: 26455870 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998-2018. Jensen MH; Hejlesen O; Vestergaard P Diabetologia; 2021 Oct; 64(10):2193-2203. PubMed ID: 34245315 [TBL] [Abstract][Full Text] [Related]
38. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials. Gebrie D; Getnet D; Manyazewal T Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333 [TBL] [Abstract][Full Text] [Related]
39. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes. Garber A; Marre M; Blonde L; Allavoine T; Howlett H; Lehert P; Cornes M Diabetes Obes Metab; 2003 May; 5(3):171-9. PubMed ID: 12681024 [TBL] [Abstract][Full Text] [Related]
40. Diabetes-specific Dementia Risk Score (DSDRS) as Predictor of Cognitive Performance of Type 2 Diabetes Patients Presenting at Teritiary Care Centre, Tamaka, Kolar. K P; Pavan TL; Sekhar S; A A; Manchu D J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]